Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06291727 · ClinicalTrials.gov registry record · Phase 4
Mepivacaine vs Bupivacaine Spinal Anesthesia for TKA
A Phase 4 study, sponsored by Prisma Health-Upstate.
- Completed
- Registry status
- Phase 4
- Development phase
- 138
- Enrollment target
NCT06291727 is a Phase 4 study that has completed, run by Prisma Health-Upstate. The registered enrollment target is 138 participants.
The verdict
NCT06291727, a Phase 4 study, has completed, sponsored by Prisma Health-Upstate.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 138 participants
- Enrollment target
Study Summary
This study is a prospective, double-blind prospective randomized controlled trial comparing mepivacaine and bupivacaine spinal anesthesia for same-day discharge readiness following a unilateral primary elective TKA procedure. Study data will be collected during the patient's hospital stay for their TKA procedure, and the primary outcome of same-day discharge readiness will be assessed the day of surgery. Patients will also be contacted at Day 3 post-op to assess for any complications, current level of pain, and pain medication utilization.
Interventions
- DRUG Bupivacaine
- DRUG Mepivacaine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 138 participants |
| Start Date | 2024-02-16 |
| Est. Completion | 2025-08-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06291727
The ClinicalTrials.gov registry entry for NCT06291727 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 138 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Prisma Health-Upstate, which has 67 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Bupivacaine is the first listed.
NCT06291727 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06291727 about?
NCT06291727 is a clinical study titled "Mepivacaine vs Bupivacaine Spinal Anesthesia for TKA". This study is a prospective, double-blind prospective randomized controlled trial comparing mepivacaine and bupivacaine spinal anesthesia for same-day discharge readiness following a unilateral primary elective TKA procedure. Study data will be collected during the patient's hospital stay for their...
What is the current status of trial NCT06291727?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 138 participants. The study started on 2024-02-16. Estimated completion is 2025-08-01.
What interventions are being tested in trial NCT06291727?
The interventions under investigation include: Bupivacaine (DRUG), Mepivacaine (DRUG).
Who is sponsoring clinical trial NCT06291727?
This trial is sponsored by Prisma Health-Upstate, which has 67 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.